PMID- 28924365 OWN - NLM STAT- MEDLINE DCOM- 20180521 LR - 20181202 IS - 1449-1907 (Electronic) IS - 1449-1907 (Linking) VI - 14 IP - 10 DP - 2017 TI - Effects of Hypobaric Hypoxia on Rat Retina and Protective Response of Resveratrol to the Stress. PG - 943-950 LID - 10.7150/ijms.19391 [doi] AB - High-altitude retinopathy represents retinal functional changes associated with environmental challenges imposed by hypobaric hypoxia, but the detailed cellular and molecular mechanism underlying this process remains unclear. Our current investigation was to explore the effect of hypobaric hypoxia on the rat retina and determine whether resveratrol has a protective efficacy on the hypoxic damage to the retina. Experiment rats were randomly grouped as the control group, hypoxia group and resveratrol intervention group. The hypoxia group and the resveratrol intervention group were maintained in a low-pressure oxygen cabin, and the resveratrol intervention group was given daily intraperitoneal injections with resveratrol. We found that hypobaric hypoxia increased thioredoxin 1 (Trx1) and thioredoxin 2 (Trx2) expression in retinas, and resveratrol treatment significantly reversed these changes (P < 0.05, P < 0.05 respectively). In comparison with controls, hypoxia upregulated the mRNA expression levels of caspase3 (P < 0.001), caspase9 (P < 0.01), heat shock protein 70 (Hsp70) (P < 0.05), heat shock protein 90 (Hsp90) (P < 0.001) and hypoxia-inducible factor-1 (HIF-1) (P < 0.05). Resveratrol administration caused a significant decrease in the gene expression of caspase3 (P< 0.001), HSP90 (P < 0.05) and HIF-1 mRNA (P < 0.01) as well as an increase in HSP70 mRNA when compared with the hypoxia group. These findings indicated that resveratrol exerted an anti-oxidative role by modulating hypoxia stress- associated genes and an anti-apoptosis role by regulating apoptosis-related cytokines. In conclusion, hypobaric hypoxia may have a pathological impact on rat retinas. The intervention of resveratrol reverses the effect induced by hypobaric hypoxia and elicits a protective response to the stress. FAU - Xin, Xiaorong AU - Xin X AD - Department of Ophthalmology, Qinghai Red Cross Hospital, Xining, Qinghai, China. FAU - Dang, Hong AU - Dang H AD - Department of Ophthalmology, Qinghai Red Cross Hospital, Xining, Qinghai, China. FAU - Zhao, Xiaojing AU - Zhao X AD - Department of Ophthalmology, Qinghai Red Cross Hospital, Xining, Qinghai, China. FAU - Wang, Haohao AU - Wang H AD - Department of Ophthalmology, Qinghai Red Cross Hospital, Xining, Qinghai, China. LA - eng PT - Journal Article DEP - 20170817 PL - Australia TA - Int J Med Sci JT - International journal of medical sciences JID - 101213954 RN - 0 (Antioxidants) RN - 0 (Cytokines) RN - 0 (Stilbenes) RN - 0 (Txn1 protein, rat) RN - 0 (Txn2 protein, rat) RN - 52500-60-4 (Thioredoxins) RN - Q369O8926L (Resveratrol) SB - IM MH - Altitude Sickness/complications/drug therapy/*metabolism MH - Animals MH - Antioxidants/*pharmacology/therapeutic use MH - Apoptosis/drug effects MH - Cytokines/metabolism MH - Disease Models, Animal MH - Humans MH - Male MH - Oxidative Stress/*drug effects MH - Rats MH - Rats, Sprague-Dawley MH - Resveratrol MH - Retina/*drug effects/pathology MH - Retinal Diseases/etiology/*prevention & control MH - Stilbenes/*pharmacology/therapeutic use MH - Thioredoxins/metabolism PMC - PMC5599917 OTO - NOTNLM OT - Caspase OT - Heat shock protein OT - Hypobaric hypoxia OT - Hypoxia-inducible factor-1. OT - Resveratrol OT - Retina COIS- Competing Interests: The authors have declared that no competing interest exists. EDAT- 2017/09/20 06:00 MHDA- 2018/05/22 06:00 PMCR- 2017/01/01 CRDT- 2017/09/20 06:00 PHST- 2017/01/29 00:00 [received] PHST- 2017/06/28 00:00 [accepted] PHST- 2017/09/20 06:00 [entrez] PHST- 2017/09/20 06:00 [pubmed] PHST- 2018/05/22 06:00 [medline] PHST- 2017/01/01 00:00 [pmc-release] AID - ijmsv14p0943 [pii] AID - 10.7150/ijms.19391 [doi] PST - epublish SO - Int J Med Sci. 2017 Aug 17;14(10):943-950. doi: 10.7150/ijms.19391. eCollection 2017.